Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv



FDA Approves Valve-in-Valve Procedures With CoreValve TAVR System

March 31, 2015 -- Medtronic plc announced US Food and Drug Administration (FDA) approval of the CoreValve transcatheter aortic valve replacement (TAVR) system for valve-in-val…

CDRH Releases Draft Guidance for Medical Device Advisory Committee Meetings

March 31, 2015 -- The US Food and Drug Administration (FDA) announced that the Center for Devices and Radiological Health (CDRH) released a draft guidance, “Procedures f…

Medtronic’s CoreValve TAVR System Approved in Japan

March 30, 2015 -- Medtronic plc announced Japanese regulatory approval for the self-expanding transcatheter CoreValve system for patients with severe aortic stenosis unable to…

New Indication Allows Brilinta to Be Crushed for Patients With Difficulty Swallowing

March 30, 2015 -- AstraZeneca announced that the US Food and Drug Administration has approved a new administration option for acute coronary syndrome (ACS) patients who are un…

House of Representatives Passes Bill That Would Repeal SGR

March 26, 2015 -- The US House of Representatives Committee on Energy and Commerce announced that the House voted 392 -- 37 to approve H.R. 2, the Medicare Access and CHI…

The Medicines Company’s Cangrelor Approved in Europe

March 30, 2015 -- The Medicines Company announced that the European Commission has granted marketing authorization for Kengrexal (cangrelor). The approval comes after the issu…

Large Meta-Analysis Compares Long and Short Durations of DAPT After DES Implantation

March 30, 2015 -- In the Journal of the American College of Cardiology (JACC), Gennaro Giustino, MD, et al published findings on the efficacy and safety of different dura…

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




2015 Buyer’s Guide


This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.

Website Design by Sides Media